Cardinal Health Q3 EPS Forecast Reduced by Leerink Partnrs

Cardinal Health, Inc. (NYSE:CAHFree Report) – Equities research analysts at Leerink Partnrs decreased their Q3 2025 EPS estimates for Cardinal Health in a research note issued on Thursday, January 30th. Leerink Partnrs analyst M. Cherny now anticipates that the company will earn $2.18 per share for the quarter, down from their prior forecast of $2.20. The consensus estimate for Cardinal Health’s current full-year earnings is $7.92 per share. Leerink Partnrs also issued estimates for Cardinal Health’s FY2025 earnings at $8.04 EPS, FY2026 earnings at $9.05 EPS, FY2027 earnings at $9.89 EPS and FY2028 earnings at $10.80 EPS.

CAH has been the topic of several other reports. Wells Fargo & Company boosted their price objective on shares of Cardinal Health from $127.00 to $135.00 and gave the company an “equal weight” rating in a research note on Wednesday, January 29th. Barclays increased their target price on shares of Cardinal Health from $117.00 to $133.00 and gave the stock an “overweight” rating in a research report on Monday, November 4th. Evercore ISI raised shares of Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price objective for the company in a research report on Tuesday, January 7th. TD Cowen upgraded Cardinal Health from a “hold” rating to a “buy” rating and increased their target price for the company from $130.00 to $144.00 in a research note on Wednesday, January 8th. Finally, Deutsche Bank Aktiengesellschaft increased their target price on Cardinal Health from $119.00 to $124.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Four investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $135.64.

Read Our Latest Stock Report on CAH

Cardinal Health Trading Up 1.5 %

Shares of CAH opened at $125.56 on Monday. The firm has a market cap of $30.33 billion, a PE ratio of 23.43, a price-to-earnings-growth ratio of 1.46 and a beta of 0.63. The company’s 50 day simple moving average is $122.11 and its 200-day simple moving average is $114.53. Cardinal Health has a 12-month low of $93.17 and a 12-month high of $132.84.

Cardinal Health (NYSE:CAHGet Free Report) last issued its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%.

Institutional Investors Weigh In On Cardinal Health

A number of institutional investors and hedge funds have recently made changes to their positions in the company. State Street Corp increased its holdings in shares of Cardinal Health by 4.6% in the third quarter. State Street Corp now owns 14,177,641 shares of the company’s stock worth $1,566,913,000 after acquiring an additional 627,253 shares in the last quarter. Geode Capital Management LLC boosted its position in Cardinal Health by 0.7% during the third quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company’s stock valued at $633,298,000 after purchasing an additional 42,082 shares during the last quarter. Pacer Advisors Inc. boosted its position in Cardinal Health by 4.7% during the third quarter. Pacer Advisors Inc. now owns 4,290,650 shares of the company’s stock valued at $474,203,000 after purchasing an additional 191,568 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its position in Cardinal Health by 2.3% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,474,625 shares of the company’s stock valued at $162,976,000 after purchasing an additional 33,388 shares during the last quarter. Finally, Two Sigma Advisers LP boosted its position in Cardinal Health by 47.9% during the third quarter. Two Sigma Advisers LP now owns 1,069,462 shares of the company’s stock valued at $118,197,000 after purchasing an additional 346,362 shares during the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a $0.5056 dividend. This represents a $2.02 annualized dividend and a yield of 1.61%. Cardinal Health’s dividend payout ratio is 37.69%.

Cardinal Health Company Profile

(Get Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

See Also

Earnings History and Estimates for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.